128 related articles for article (PubMed ID: 17467669)
21. The SH3 domain of Caskin1 binds to lysophosphatidic acid suggesting a direct role for the lipid in intracellular signaling.
Koprivanacz K; Tőke O; Besztercei B; Juhász T; Radnai L; Merő B; Mihály J; Péter M; Balogh G; Vígh L; Buday L; Liliom K
Cell Signal; 2017 Apr; 32():66-75. PubMed ID: 28104445
[TBL] [Abstract][Full Text] [Related]
22. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
[TBL] [Abstract][Full Text] [Related]
23. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
Simon JA; Schreiber SL
Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
[TBL] [Abstract][Full Text] [Related]
24. Solution structure of N-terminal SH3 domain of Vav and the recognition site for Grb2 C-terminal SH3 domain.
Ogura K; Nagata K; Horiuchi M; Ebisui E; Hasuda T; Yuzawa S; Nishida M; Hatanaka H; Inagaki F
J Biomol NMR; 2002 Jan; 22(1):37-46. PubMed ID: 11885979
[TBL] [Abstract][Full Text] [Related]
25. Promiscuous binding nature of SH3 domains to their target proteins.
Agrawal V; Kishan KV
Protein Pept Lett; 2002 Jun; 9(3):185-93. PubMed ID: 12144515
[TBL] [Abstract][Full Text] [Related]
26. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C
J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825
[TBL] [Abstract][Full Text] [Related]
27. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
[TBL] [Abstract][Full Text] [Related]
28. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.
Kami K; Takeya R; Sumimoto H; Kohda D
EMBO J; 2002 Aug; 21(16):4268-76. PubMed ID: 12169629
[TBL] [Abstract][Full Text] [Related]
29. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
30. Making ends meet: the importance of the N- and C-termini for the structure, stability, and function of the third SH3 domain of CIN85.
Philippe D; Ababou A; Yang X; Ghosh R; Daviter T; Ladbury JE; Pfuhl M
Biochemistry; 2011 May; 50(18):3649-59. PubMed ID: 21446695
[TBL] [Abstract][Full Text] [Related]
31. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
32. NMR evidence for forming highly populated helical conformations in the partially folded hNck2 SH3 domain.
Liu J; Song J
Biophys J; 2008 Nov; 95(10):4803-12. PubMed ID: 18599634
[TBL] [Abstract][Full Text] [Related]
33. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
[TBL] [Abstract][Full Text] [Related]
34. Competitive binding of UBPY and ubiquitin to the STAM2 SH3 domain revealed by NMR.
Lange A; Ismail MB; Rivière G; Hologne M; Lacabanne D; Guillière F; Lancelin JM; Krimm I; Walker O
FEBS Lett; 2012 Sep; 586(19):3379-84. PubMed ID: 22841719
[TBL] [Abstract][Full Text] [Related]
35. Distinct ubiquitin binding modes exhibited by SH3 domains: molecular determinants and functional implications.
Ortega Roldan JL; Casares S; Ringkjøbing Jensen M; Cárdenes N; Bravo J; Blackledge M; Azuaga AI; van Nuland NA
PLoS One; 2013; 8(9):e73018. PubMed ID: 24039852
[TBL] [Abstract][Full Text] [Related]
36. Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src.
Suzuki A; Kadota N; Hara T; Nakagami Y; Izumi T; Takenawa T; Sabe H; Endo T
Oncogene; 2000 Nov; 19(51):5842-50. PubMed ID: 11127814
[TBL] [Abstract][Full Text] [Related]
37. High resolution crystal structures of the p120 RasGAP SH3 domain.
Ross B; Kristensen O; Favre D; Walicki J; Kastrup JS; Widmann C; Gajhede M
Biochem Biophys Res Commun; 2007 Feb; 353(2):463-8. PubMed ID: 17188236
[TBL] [Abstract][Full Text] [Related]
38. Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR-ABL(+) chronic myeloid leukemia cells to tyrosine kinase inhibitors.
Liu X; Chen M; Lobo P; An J; Grace Cheng SW; Moradian A; Morin GB; Van Petegem F; Jiang X
Proteomics; 2012 Jul; 12(13):2094-106. PubMed ID: 22623184
[TBL] [Abstract][Full Text] [Related]
39. Effect of pH and salt bridges on structural assembly: molecular structures of the monomer and intertwined dimer of the Eps8 SH3 domain.
Kishan KV; Newcomer ME; Rhodes TH; Guilliot SD
Protein Sci; 2001 May; 10(5):1046-55. PubMed ID: 11316885
[TBL] [Abstract][Full Text] [Related]
40. Why ligand cross-reactivity is high within peptide recognition domain families? A case study on human c-Src SH3 domain.
He P; Wu W; Wang HD; Liao KL; Zhang W; Lv FL; Yang K
J Theor Biol; 2014 Jan; 340():30-7. PubMed ID: 24021866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
